Performance assessment of a glucose control protocol in septic patients with an automated intermittent plasma glucose monitoring device

Clinical Nutrition

Volumn 33, Issue 5, 2014, Pages 867-871

  Umbrello, M ^a   Salice, V ^b   Spanu, P ^a   Formenti, P ^a   Barassi, A ^b   Melzi d'Eril, G V ^b   Iapichino, G ^a,b  

^a Azienda Ospedaliera San Paolo Polo Universitario   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Automated glucose control; Blood glucose; Critically ill patients; Glucose control protocol; Sepsis

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; AGED; BLOOD; BLOOD GLUCOSE MONITORING; BODY MASS; CRITICAL ILLNESS; DEVICES; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INTENSIVE CARE UNIT; MALE; METABOLISM; MIDDLE AGED; PILOT STUDY; PROCEDURES; PROSPECTIVE STUDY; SEPSIS;

ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BODY MASS INDEX; CRITICAL ILLNESS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; SEPSIS;

EID: 84906043660     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.10.007     Document Type: Article

References (31)

1. Dungan K.M., Braithwaite S.S., Preiser J.C. Stress hyperglycaemia. Lancet 2009, 373:1798-1807.
2. Badawi O., Waite M.D., Fuhrman S.A., Zuckerman I.H. Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Critical Care Medicine 2012, 40:3180-3188.
3. Savioli M., Cugno M., Polli F., Taccone P., Bellani G., Spanu P., et al. Tight glycemic control may favor fibrinolysis in patients with sepsis. Critical Care Medicine 2009, 37:424-431.
4. Vanhorebeek I., Langouche L. Molecular mechanisms behind clinical benefits of intensive insulin therapy during critical illness: glucose versus insulin. Best Practice & Research Clinical Anaesthesiology 2009, 23:449-459.
5. van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in critically ill patients. The New England Journal of Medicine 2001, 345:1359-1367.
6. Van den Berghe G., Wilmer A., Hermans G., Meersseman W., Wouters P.J., Milants I., et al. Intensive insulin therapy in the medical ICU. The New England Journal of Medicine 2006, 354:449-461.
7. Preiser J.C., Devos P., Ruiz-Santana S., Melot C., Annane D., Groeneveld J., et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Medicine 2009, 35:1738-1748.
8. Brunkhorst F.M., Engel C., Bloos F., Meier-Hellmann A., Ragaller M., Weiler N., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. The New England Journal of Medicine 2008, 358:125-139.
9. Finfer S., Chittock D.R., Su S.Y., Blair D., Foster D., Dhingra V., et al. Intensive versus conventional glucose control in critically ill patients. The New England Journal of Medicine 2009, 360:1283-1297.
10. Inzucchi S.E., Siegel M.D. Glucose control in the ICU - how tight is too tight?. The New England Journal of Medicine 2009, 360:1346-1349.
11. Finfer S., Liu B., Chittock D.R., Norton R., Myburgh J.A., McArthur C., et al. Hypoglycemia and risk of death in critically ill patients. The New England Journal of Medicine 2012, 367:1108-1118.
12. Egi M., Bellomo R., Stachowski E., French C.J., Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006, 105:244-252.
13. Meyfroidt G., Keenan D.M., Wang X., Wouters P.J., Veldhuis J.D., Van den Berghe G. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Critical Care Medicine 2010, 38:1021-1029.
14. Mackenzie I.M., Whitehouse T., Nightingale P.G. The metrics of glycaemic control in critical care. Intensive Care Medicine 2011, 37:435-443.
15. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Medicine 2013, 39:165-228.
16. Meijering S., Corstjens A.M., Tulleken J.E., Meertens J.H., Zijlstra J.G., Ligtenberg J.J. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Critical Care 2006, 10:R19.
17. Zauner A., Nimmerrichter P., Anderwald C., Bischof M., Schiefermeier M., Ratheiser K., et al. Severity of insulin resistance in critically ill medical patients. Metabolism Clinical and Experimental 2007, 56:1-5.
18. Saberi F., Heyland D., Lam M., Rapson D., Jeejeebhoy K. Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study. Journal of Parenteral and Enteral Nutrition 2008, 32:227-235.
19. Iapichino G. Algorithm to manage blood glucose in critically ill patients: who control the driver?. Minerva Anestesiologica 2010, 76:982-985.
20. Jax T., Heise T., Nosek L., Gable J., Lim G., Calentine C. Automated near-continuous glucose monitoring measured in plasma using mid-infrared spectroscopy. Journal of Diabetes Science and Technology 2011, 5:345-352.
21. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
22. Iapichino G., Radrizzani D., Colombo A., Ronzoni G., Pasetti G., Bonetti G., et al. Plasma amino acid concentration changes during total parental nutrition in critically ill patients. Clinical Nutrition 1992, 11:358-364.
23. Vogelzang M., van der Horst I.C., Nijsten M.W. Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Critical Care 2004, 8:R122-R127.
24. Krinsley J.S. Glycemic control in the critically ill - 3 domains and diabetic status means one size does not fit all!. Critical Care 2013, 17:131.
25. Fahy B.G., Coursin D.B. An analysis: hyperglycemic intensive care patients need continuous glucose monitoring-easier said than done. Journal of Diabetes Science and Technology 2008, 2:201-204.
26. Desachy A., Vuagnat A.C., Ghazali A.D., Baudin O.T., Longuet O.H., Calvat S.N., et al. Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index. Mayo Clinic Proceedings Mayo Clinic 2008, 83:400-405.
27. Finfer S., Wernerman J., Preiser J.C., Cass T., Desaive T., Hovorka R., et al. Clinical review: consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Critical Care 2013, 17:229.
28. Holzinger U., Warszawska J., Kitzberger R., Herkner H., Metnitz P.G., Madl C. Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring. Intensive Care Medicine 2009, 35:1383-1389.
29. Blixt C., Rooyackers O., Isaksson B., Wernerman J. Continuous on-line glucose measurement by microdialysis in a central vein. A pilot study. Critical Care 2013, 17:R87.
30. Waeschle R.M., Moerer O., Hilgers R., Herrmann P., Neumann P., Quintel M. The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability. Critical Care 2008, 12:R129.
31. Duckworth W.C., Bennett R.G., Hamel F.G. Insulin degradation: progress and potential. Endocrine Reviews 1998, 19:608-624.